SK284622B6 - Farmaceutická kompozícia s obsahom antioxidantu a použitie antioxidantu na stabilizáciu tejto kompozície - Google Patents

Farmaceutická kompozícia s obsahom antioxidantu a použitie antioxidantu na stabilizáciu tejto kompozície Download PDF

Info

Publication number
SK284622B6
SK284622B6 SK1053-2000A SK10532000A SK284622B6 SK 284622 B6 SK284622 B6 SK 284622B6 SK 10532000 A SK10532000 A SK 10532000A SK 284622 B6 SK284622 B6 SK 284622B6
Authority
SK
Slovakia
Prior art keywords
pharmaceutical composition
weight
antioxidant
compound
tocopherol
Prior art date
Application number
SK1053-2000A
Other languages
English (en)
Slovak (sk)
Other versions
SK10532000A3 (sk
Inventor
Bodo Asmussen
Michael Horstmann
Kai K�Pke
Harry Tiemessen
Original Assignee
Novartis Ag
Lts Lohmann Therapie-Systeme Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10825116&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SK284622(B6) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag, Lts Lohmann Therapie-Systeme Ag filed Critical Novartis Ag
Publication of SK10532000A3 publication Critical patent/SK10532000A3/sk
Publication of SK284622B6 publication Critical patent/SK284622B6/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Emergency Medicine (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Anti-Oxidant Or Stabilizer Compositions (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Fats And Perfumes (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Dental Preparations (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
SK1053-2000A 1998-01-12 1999-01-08 Farmaceutická kompozícia s obsahom antioxidantu a použitie antioxidantu na stabilizáciu tejto kompozície SK284622B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9800526.7A GB9800526D0 (en) 1998-01-12 1998-01-12 Organic compounds
PCT/EP1999/000078 WO1999034782A1 (fr) 1998-01-12 1999-01-08 Systeme transdermique contenant un antioxydant

Publications (2)

Publication Number Publication Date
SK10532000A3 SK10532000A3 (sk) 2000-11-07
SK284622B6 true SK284622B6 (sk) 2005-08-04

Family

ID=10825116

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1053-2000A SK284622B6 (sk) 1998-01-12 1999-01-08 Farmaceutická kompozícia s obsahom antioxidantu a použitie antioxidantu na stabilizáciu tejto kompozície

Country Status (26)

Country Link
US (1) US6335031B1 (fr)
EP (1) EP1047409B1 (fr)
KR (1) KR100569051B1 (fr)
CN (1) CN1129427C (fr)
AT (1) ATE223711T1 (fr)
AU (1) AU745661B2 (fr)
BR (1) BR9906920A (fr)
CA (1) CA2315784C (fr)
CZ (1) CZ300598B6 (fr)
DE (1) DE69902875T2 (fr)
DK (1) DK1047409T3 (fr)
ES (1) ES2184408T3 (fr)
GB (1) GB9800526D0 (fr)
HK (1) HK1034036A1 (fr)
HU (1) HU227159B1 (fr)
ID (1) ID27503A (fr)
IL (1) IL137100A (fr)
MX (1) MXPA00006438A (fr)
NO (1) NO328390B1 (fr)
NZ (1) NZ505650A (fr)
PL (1) PL201328B1 (fr)
PT (1) PT1047409E (fr)
RU (1) RU2219926C2 (fr)
SK (1) SK284622B6 (fr)
TR (2) TR200001688T2 (fr)
WO (1) WO1999034782A1 (fr)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1406126A (zh) * 1998-10-01 2003-03-26 诺瓦提斯公司 新型缓释口服制剂
FR2793689B1 (fr) * 1999-05-19 2001-08-24 Pf Medicament Dispositif transdermique pour l'administration de testosterone ou d'un de ses derives
ATE245972T1 (de) * 1999-11-29 2003-08-15 Lohmann Therapie Syst Lts Transdermale therapeutische systeme mit verbesserter stabilität und ein verfahren zu ihrer herstellung
DE10107663B4 (de) * 2001-02-19 2004-09-09 Lts Lohmann Therapie-Systeme Ag Testosteronhaltiges transdermales therapeutisches System, Verfahren zu seiner Herstellung und seine Verwendung
ITMI20020798A1 (it) * 2002-04-15 2003-10-15 F T Holding S A Cerotti transdermici a matrice adesiva siliconica stabilizzati con copolimeri metacrilici
FR2881653A1 (fr) * 2005-02-04 2006-08-11 Frederic Khodja Dispositif permettant l'administration en continu d'une dose physiologique controlee d'au moins un mineral ou une vitamine
TWI389709B (zh) * 2005-12-01 2013-03-21 Novartis Ag 經皮治療系統
WO2009022345A1 (fr) * 2007-08-14 2009-02-19 Yissum Research Development Company Of The Hebrew University Of Jerusalem Carbamates de phényle destinés au traitement de la sclérose en plaques
ES2660962T3 (es) 2008-07-28 2018-03-26 Takeda Pharmaceutical Company Limited Composición farmacéutica fotoestabilizada
US20100087768A1 (en) * 2008-10-02 2010-04-08 Forlano Paula Transdermal drug delivery system for liquid active ingredient
DK2515886T3 (en) 2009-12-22 2018-06-14 Luye Pharma Ag Transdermal therapeutic system for administration of rivastigmine or derivatives thereof
US10076502B2 (en) 2009-12-22 2018-09-18 Luye Pharma Ag Transdermal therapeutic system for administering rivastigmine or derivatives thereof
ES2363395B1 (es) * 2010-01-20 2012-02-23 Farmalider, S.A. Composición farmacéutica l�?quida de rivastigmina o de una de sus sales de adición de �?cido para la administración por v�?a oral.
WO2011151359A1 (fr) 2010-06-02 2011-12-08 Noscira, S.A. Traitement combiné comprenant un inhibiteur de la cholinestérase et un dérivé de thiadiazolidinedione
DE102010026903A1 (de) 2010-07-12 2012-01-12 Amw Gmbh Transdermales therapeutisches System mit Avocadoöl oder Palmöl als Hilfsstoff
ES2720952T3 (es) 2010-07-21 2019-07-25 3M Innovative Properties Co Composiciones adhesivas transdérmicas, dispositivos y métodos
EP2468274B1 (fr) * 2010-12-14 2015-07-01 Acino AG Système thérapeutique transdermique pour l'enrichissement d'une substance active
KR101788802B1 (ko) * 2010-12-24 2017-10-20 주식회사 삼양바이오팜 리바스티그민을 함유하는 경피흡수제제
KR20120126898A (ko) * 2011-05-13 2012-11-21 에스케이케미칼주식회사 리바스티그민 또는 이의 염을 함유하는 경피 투여 조성물
KR20120130073A (ko) * 2011-05-20 2012-11-28 에스케이케미칼주식회사 리바스티그민 함유 패취
US9585862B2 (en) 2011-05-20 2017-03-07 Sk Chemicals Co., Ltd. Patch containing rivastigmine
EP2594261A1 (fr) 2011-11-18 2013-05-22 Labtec GmbH Composition pour administration transdermique de rivastigmine
DE102012000369A1 (de) 2012-01-11 2013-07-11 Alfred E. Tiefenbacher (Gmbh & Co. Kg) Transdermales therapeutisches System mit Cholinesterase-Hemmer
WO2013142339A1 (fr) 2012-03-23 2013-09-26 Novartis Ag Système thérapeutique transdermique et procédé associé
JP6153135B2 (ja) 2012-06-12 2017-06-28 株式会社 ケイ・エム トランスダーム 貼付剤
US20150209302A1 (en) * 2012-09-03 2015-07-30 Nipro Patch Co., Ltd. Adhesive skin patch
KR20140038237A (ko) * 2012-09-20 2014-03-28 에스케이케미칼주식회사 리바스티그민의 안정성이 개선된 의약품
US9895320B2 (en) 2012-09-28 2018-02-20 KM Transderm Ltd. Transdermal patch with different viscosity hydrocarbon oils in the drug layer and the adhesive layer
WO2014111790A2 (fr) 2013-01-15 2014-07-24 Zydus Technologies Limited Système d'administration de médicament pharmaceutique transdermique stable comprenant de la rivastigmine
EP3129012A4 (fr) * 2014-04-08 2017-10-11 Teikoku Pharma USA, Inc. Compositions transdermiques à base de rivastigmine et leurs méthodes d'utilisation
WO2015174502A1 (fr) 2014-05-15 2015-11-19 ニチバン株式会社 Emballage pour timbre adhésif contenant de la rivastigmine
KR20200025883A (ko) 2018-08-31 2020-03-10 에스케이케미칼 주식회사 장기 투여용 리바스티그민 패취
KR20200025888A (ko) 2018-08-31 2020-03-10 에스케이케미칼 주식회사 장기 투여용 리바스티그민 패취

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU201906B (en) * 1987-03-04 1991-01-28 Sandoz Ag Process for producing phenyl-carbamate derivative and acid additional salts and pharmaceutical compositions containing them
WO1998030243A1 (fr) * 1997-01-08 1998-07-16 Warner-Lambert Company Inhibiteurs d'acetylcholinesterase en combinaison avec des agonistes muscariniques utilises dans le traitement de la maladie d'alzheimer
DE69802498T2 (de) * 1997-01-17 2002-07-04 Takeda Chemical Industries Ltd Idebenon enthaltendes kombinationspräparat zur alzheimer behandlung

Also Published As

Publication number Publication date
CN1288375A (zh) 2001-03-21
CA2315784A1 (fr) 1999-07-15
HU227159B1 (en) 2010-09-28
PT1047409E (pt) 2002-12-31
NO20003472L (no) 2000-08-07
NZ505650A (en) 2002-10-25
MXPA00006438A (es) 2003-07-21
HK1034036A1 (en) 2001-10-12
TR200001688T2 (tr) 2000-11-21
TR200101021T2 (tr) 2002-06-21
PL341347A1 (en) 2001-04-09
KR100569051B1 (ko) 2006-04-10
NO328390B1 (no) 2010-02-08
AU2278599A (en) 1999-07-26
HUP0004300A3 (en) 2003-05-28
EP1047409B1 (fr) 2002-09-11
WO1999034782A1 (fr) 1999-07-15
GB9800526D0 (en) 1998-03-11
ATE223711T1 (de) 2002-09-15
DE69902875T2 (de) 2003-05-22
DK1047409T3 (da) 2002-12-30
IL137100A (en) 2004-12-15
AU745661B2 (en) 2002-03-28
ID27503A (id) 2001-04-12
CA2315784C (fr) 2006-06-27
JP3820103B2 (ja) 2006-09-13
BR9906920A (pt) 2000-10-10
CZ20002557A3 (cs) 2000-10-11
JP2002500178A (ja) 2002-01-08
EP1047409A1 (fr) 2000-11-02
PL201328B1 (pl) 2009-03-31
CZ300598B6 (cs) 2009-06-24
IL137100A0 (en) 2001-06-14
CN1129427C (zh) 2003-12-03
DE69902875D1 (de) 2002-10-17
US6335031B1 (en) 2002-01-01
SK10532000A3 (sk) 2000-11-07
KR20010033072A (ko) 2001-04-25
ES2184408T3 (es) 2003-04-01
NO20003472D0 (no) 2000-07-05
HUP0004300A2 (hu) 2001-05-28
RU2219926C2 (ru) 2003-12-27

Similar Documents

Publication Publication Date Title
SK284622B6 (sk) Farmaceutická kompozícia s obsahom antioxidantu a použitie antioxidantu na stabilizáciu tejto kompozície
KR101674240B1 (ko) 리바스티그민 또는 그의 유도체 투여용 경피 치료 시스템
US20200289426A1 (en) Transdermal Therapeutic System for Administering an Active Substance
FI114782B (fi) Menetelmä laminaatin muodossa olevan lääkelaastarin valmistamiseksi
PL175083B1 (pl) Przezskórny układ terapeutyczny do podawania galantaminy na skórę
KR101942677B1 (ko) 첩부제
EP0155229B1 (fr) Compositions pharmaceutiques
KR20180054833A (ko) 첩부제
US6316023B1 (en) TTS containing an antioxidant
WO2014111790A2 (fr) Système d'administration de médicament pharmaceutique transdermique stable comprenant de la rivastigmine
KR20220128273A (ko) 로티고틴 함유 경피 흡수 제제
US10076502B2 (en) Transdermal therapeutic system for administering rivastigmine or derivatives thereof
JP3820103B6 (ja) 抗酸化剤含有ｔｔｓ
US20090246266A1 (en) Preparation and composition of meloxicam transdermal drug delivery system
KR101764929B1 (ko) 셀레길린-함유 접착 제제
JP2002500178A5 (fr)
EP4226922A1 (fr) Procédé de suppression de la dégradation de l'asénapine
EP4226921A1 (fr) Patch transdermique contenant de l'asénapine
DK175236B1 (da) Farmaceutisk præparat

Legal Events

Date Code Title Description
MK4A Patent expired

Expiry date: 20190108